
Category: lung disease
February 28, 2023 / J Immunother Cancer
Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody
Background: Immunotherapy for malignant tumors has made great progress, but many patients do not benefit from it. The complex intratumoral heterogeneity (ITH) hindered the in-depth exploration of immunotherapy. Conventional bulk…
December 27, 2022 / Sci Rep
Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer
October 10, 2022 / Nat Commun
The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
September 15, 2022 / Immunology
Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage
September 13, 2022 / Cancer Discov
Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma
August 24, 2022 / Lancet Respir Med
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
July 11, 2022 / Am J Respir Crit Care Med
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
July 7, 2022 / Sci Transl Med
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
July 6, 2022 / J Immunother Cancer